Literature DB >> 1839823

Cyclin A, cell cycle control and oncogenesis.

M Pagano1, G Draetta.   

Abstract

One of the most fundamental questions in biology is how a cell is able to regulate its division cycle. Initially it was thought that in mammalian cells control over entry into the cell cycle is exerted at a restriction point in G1; once past this point the cell would be free to undergo all the steps needed until the following division. Hence, for many years research on tumorigenesis focused on the mitogenic activation of quiescent cells by growth factors, peptide hormones and oncogene products (for reviews see [1, 2]). These studies investigated the initial steps required to induce a quiescent, nondividing cell to proliferate, and led to the identification of many growth factor receptors, of both the tyrosine kinase family and the G-protein coupled family. Receptors bearing protein tyrosine phosphatase or serine kinase catalytic domains were also identified via this route (for reviews see [3, 4, 5]). However more recent studies on the cooperation between different growth factors for mitogenesis have shown that multiple requirements exist for a cell to proceed through the entire division cycle. Indeed studies in several different organisms, pioneered by investigators working with Ascomycetes [6, 7, 8], have now clearly shown that the eukaryotic cell cycle proceeds through multiple check-points. Furthermore, it now appears that many of the regulatory elements and even pathways have been conserved throughout evolution. In this review we discuss the possible involvement of one of the transducing molecules, cyclin A, in abnormal cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1839823     DOI: 10.1016/0955-2235(91)90004-n

Source DB:  PubMed          Journal:  Prog Growth Factor Res        ISSN: 0955-2235


  9 in total

1.  Cytokine and integrin stimulation synergize to promote higher levels of GATA-2, c-myb, and CD34 protein in primary human hematopoietic progenitors from bone marrow.

Authors:  Mo A Dao; Jan A Nolta
Journal:  Blood       Date:  2006-11-09       Impact factor: 22.113

2.  Cyclin A transcriptional suppression is the major mechanism mediating homocysteine-induced endothelial cell growth inhibition.

Authors:  Hong Wang; XiaoHua Jiang; Fan Yang; Gary B Chapman; William Durante; Nicholas E S Sibinga; Andrew I Schafer
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

3.  TR1 promotes cell proliferation and inhibits apoptosis through cyclin A and CTGF regulation in non-small cell lung cancer.

Authors:  Li Wang; Zhenhong Chen; Yajuan Wang; De Chang; Longxiang Su; Yinghua Guo; Changting Liu
Journal:  Tumour Biol       Date:  2014-01

4.  Function of a human cyclin gene as an oncogene.

Authors:  P W Hinds; S F Dowdy; E N Eaton; A Arnold; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

5.  Histone deacetylase 3 regulates cyclin A stability.

Authors:  Miriam Vidal-Laliena; Edurne Gallastegui; Francesca Mateo; Marian Martínez-Balbás; Maria Jesús Pujol; Oriol Bachs
Journal:  J Biol Chem       Date:  2013-06-11       Impact factor: 5.157

6.  Cyclins and cell cycle control in cancer and disease.

Authors:  Mathew C Casimiro; Marco Crosariol; Emanuele Loro; Zhiping Li; Richard G Pestell
Journal:  Genes Cancer       Date:  2012-11

7.  Modulation of cyclin gene expression by adenovirus E1A in a cell line with E1A-dependent conditional proliferation.

Authors:  D Spitkovsky; P Steiner; J Lukas; E Lees; M Pagano; A Schulze; S Joswig; D Picard; M Tommasino; M Eilers
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

8.  Degradation of cyclin A is regulated by acetylation.

Authors:  F Mateo; M Vidal-Laliena; N Canela; L Busino; M A Martinez-Balbas; M Pagano; N Agell; O Bachs
Journal:  Oncogene       Date:  2009-06-01       Impact factor: 9.867

9.  Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts.

Authors:  M Pagano; R Pepperkok; J Lukas; V Baldin; W Ansorge; J Bartek; G Draetta
Journal:  J Cell Biol       Date:  1993-04       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.